Anticholinergic Risk and Frequency of Anticholinergic Drug Prescriptions in a Population Older Than 65

Journal of the American Medical Directors Association
J E Machado-AlbaDiego Alejandro Medina-Morales

Abstract

To determine the risk and frequency of anticholinergic drug prescriptions in a population affiliated with the Colombian General System of Social Security in Health. A cross-sectional study was conducted in 2013. Patients older than 65 years who received drugs with the potential to block cholinergic receptors, in accordance with an anticholinergic risk scale. The total anticholinergic load was determined by the sum of the risk of each prescribed drug. The study included a total of 27,654 patients with a mean age of 76.1 ± 7.6 years, and 61.9% were women. A total of 9.1% of the population older than 65 years had received a prescription of at least one of these drugs, and the prevalence of these prescriptions was 112.5 per 1000 members. The average number of drugs prescribed per patient was 1.4, and the drugs most frequently prescribed contained trazodone, methocarbamol, and loratadine. Being prescribed by practitioners of surgical or related specialties was the only variable significantly associated with prescriptions with high anticholinergic risk in the multivariate analysis (odds ratio 1.61; 95% confidence interval 1.335-1.934; P < .001). We found a high frequency of prescription medications with some degree of anticholinergic...Continue Reading

References

Jul 27, 1994·JAMA : the Journal of the American Medical Association·S M WillcoxS Woolhandler
May 27, 2004·Journal of the American Geriatrics Society·Christopher J LanePaula A Rochon
Aug 11, 2004·Archives of Internal Medicine·Lesley H CurtisKevin A Schulman
Mar 12, 2008·Archives of Internal Medicine·James L RudolphRegina E McGlinchey
Jun 26, 2009·Clinical Interventions in Aging·Noll CampbellRajesh Gulati
Mar 7, 2012·Expert Review of Clinical Pharmacology·May P S Lam, Bernard M Y Cheung
Apr 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Arduino A MangoniSophia E de Rooij
Jan 20, 2015·Journal of the American Geriatrics Society·Mohammed Saji SalahudeenPrasad S Nishtala

❮ Previous
Next ❯

Citations

Dec 11, 2017·International Psychogeriatrics·Manuel E Machado-DuqueJorge E Machado-Alba
Jul 26, 2019·Geriatrics & Gerontology International·Luis Fernando Valladales-RestrepoJorge Enrique Machado-Alba
Feb 25, 2020·PloS One·Luis Fernando Valladales-RestrepoJorge Enrique Machado-Alba
Sep 24, 2020·Pharmacology Research & Perspectives·Juan-Sebastian Franco, David Vizcaya
Apr 13, 2018·Geriatrics & Gerontology International·Daniel Sevilla-SánchezCarles Codina-Jané
Apr 9, 2019·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Luis Fernando Valladales-Restrepo, Jorge Enrique Machado-Alba
Mar 13, 2018·Journal of Geriatric Psychiatry and Neurology·Manuel E Machado-DuqueJorge E Machado-Alba
May 3, 2021·Neuroscience and Biobehavioral Reviews·Yong-Bo ZhengLin Lu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revista Panamericana De Salud Pública = Pan American Journal of Public Health
J E Machado-AlbaDiego Romero
Revista Panamericana De Salud Pública = Pan American Journal of Public Health
J E Machado-AlbaMónica Johanna Solarte Gómez
Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Jorge Enrique MachadoGiovanny Mesa
© 2022 Meta ULC. All rights reserved